NTRA Natera, Inc.

NASDAQ
$319.09

Natera, Inc. (NTRA) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Moderately bearish Selling ran elevated versus NTRA's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 7 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
7
177 transactions
Purchases
$0
0 shares
Sales
$104.8M
290,819 shares
Net activity
-$104.8M
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $104.8M 177 transactions · 290,819 shares
Discretionary sales $0 0 transactions · 0 shares

Largest single sale: $5.9M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Sheena Jonathan 14 fills Director Sell 10b5-1 1,500 $319.30 $478.9K 8,210 −15.4% of holding
Sheena Jonathan 19 fills Director Sell 10b5-1 3,150 $316.00 $995.4K 217,597 −1.4% of holding
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sell 10b5-1 470 $391.49 $184.0K 45,779 −1% of holding
Chapman Steven Leonard 3 fills CEO AND PRESIDENT Sell 10b5-1 3,801 $411.80 $1.6M 91,211 −4% of holding
Moshkevich Solomon 12 fills PRESIDENT, CLINICALDIAGNOSTICS Sell 10b5-1 3,419 $409.77 $1.4M 104,733 −3.2% of holding
Rabinowitz Matthew 2 fills EXECUTIVE CHAIRMAN Sell 10b5-1 748 $400.02 $299.2K 2,117,659 −0% of holding
RABINOWITZ DANIEL 2 fills SEC. AND CHIEF LEGAL OFFICER Sell 10b5-1 341 $400.05 $136.4K 168,214 −0.2% of holding
Brophy Michael Burkes 2 fills CHIEF FINANCIAL OFFICER Sell 10b5-1 325 $399.99 $130.0K 46,566 −0.7% of holding
Fesko John 2 fills PRESIDENT, CHIEF BUS. OFFICER Sell 10b5-1 302 $400.01 $120.8K 195,571 −0.2% of holding
Sheena Jonathan 2 fills Director Sell 10b5-1 112 $399.97 $44.8K 217,683 −0.1% of holding
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sell 10b5-1 1,906 $425.55 $811.1K 46,574 −3.9% of holding
Chapman Steven Leonard CEO AND PRESIDENT Sell 10b5-1 3,430 $426.34 $1.5M 91,232 −3.6% of holding
Brophy Michael Burkes 3 fills CHIEF FINANCIAL OFFICER Sell 10b5-1 2,376 $426.40 $1.0M 49,658 −4.6% of holding
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sell 10b5-1 1,162 $426.34 $495.4K 104,742 −1.1% of holding
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Sell 10b5-1 968 $426.34 $412.7K 168,221 −0.6% of holding
Fesko John PRESIDENT, CHIEF BUS. OFFICER Sell 10b5-1 898 $426.34 $382.9K 195,578 −0.5% of holding
Sheena Jonathan Director Sell 10b5-1 187 $426.34 $79.7K 217,686 −0.1% of holding
Chapman Steven Leonard CEO AND PRESIDENT Sell 10b5-1 2,264 $406.00 $919.2K 94,662 −2.3% of holding
Rabinowitz Matthew EXECUTIVE CHAIRMAN Sell 10b5-1 1,718 $406.00 $697.5K 2,117,676 −0.1% of holding
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sell 10b5-1 1,010 $406.00 $410.1K 105,904 −0.9% of holding
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER Sell 10b5-1 884 $406.00 $358.9K 169,189 −0.5% of holding
Fesko John PRESIDENT, CHIEF BUS. OFFICER Sell 10b5-1 781 $406.00 $317.1K 196,476 −0.4% of holding
Brophy Michael Burkes CHIEF FINANCIAL OFFICER Sell 10b5-1 781 $406.00 $317.1K 50,856 −1.5% of holding
Sheena Jonathan Director Sell 10b5-1 291 $406.00 $118.1K 217,873 −0.1% of holding
Sheena Jonathan 8 fills Director Sell 10b5-1 3,150 $410.55 $1.3M 221,114 −1.4% of holding
Sheena Jonathan 12 fills Director Sell 10b5-1 1,500 $402.47 $603.7K 8,858 −14.5% of holding
Rabinowitz Matthew 19 fills EXECUTIVE CHAIRMAN Sell 10b5-1 50,000 $402.64 $20.1M 2,169,108 −2.3% of holding
Moshkevich Solomon 3 fills PRESIDENT, CLINICALDIAGNOSTICS Sell 10b5-1 3,000 $414.22 $1.2M 109,714 −2.7% of holding
Chapman Steven Leonard CEO AND PRESIDENT Sell 10b5-1 1,273 $413.31 $526.1K 96,926 −1.3% of holding
Sheena Jonathan 12 fills Director Sell 10b5-1 18,064 $388.01 $7.0M 17,642 −50.6% of holding
Sheena Jonathan 6 fills Director Sell 10b5-1 3,150 $354.19 $1.1M 224,264 −1.4% of holding
Rabinowitz Matthew 14 fills EXECUTIVE CHAIRMAN Sell 10b5-1 52,000 $347.29 $18.1M 2,173,913 −2.3% of holding
Sheena Jonathan Director Sell 10b5-1 6,000 $350.07 $2.1M 224,464 −2.6% of holding
Rabinowitz Matthew 15 fills EXECUTIVE CHAIRMAN Sell 10b5-1 50,000 $334.76 $16.7M 2,223,857 −2.2% of holding
Rabinowitz Matthew 6 fills EXECUTIVE CHAIRMAN Sell 10b5-1 50,000 $327.97 $16.4M 2,274,594 −2.2% of holding
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS Sell 10b5-1 15,160 $326.89 $5.0M 110,859 −12% of holding
Moshkevich Solomon 3 fills PRESIDENT, CLINICALDIAGNOSTICS Sell 10b5-1 3,000 $320.73 $962.2K 128,019 −2.3% of holding
Chapman Steven Leonard CEO AND PRESIDENT Sell 10b5-1 1,698 $320.99 $545.0K 98,199 −1.7% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.